Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pall Opens New Life Sciences CoE in Shanghai

Published: Thursday, October 17, 2013
Last Updated: Thursday, October 17, 2013
Bookmark and Share
New Centre of Excellence extends Pall’s local capabilities in the region.

Pall Corporation has inaugurated the Pall Life Sciences Centre of Excellence (CoE) at its new Zhangjiang site in Shanghai in the People’s Republic of China.

The new Centre of Excellence, which offers biopharmaceutical process solutions, technical and validation support as well as training, extends Pall’s local capabilities for its growing base of life sciences customers in the region.

“This year marks the 20th anniversary of Pall’s expansion into China. The opening of the Shanghai Life Sciences Centre of Excellence is another milestone in Pall’s development in China,” said Larry Kingsley, Chairman and CEO of Pall Corporation.

Kingsley continued, “The new Centre of Excellence not only reinforces our commitment to investing in the region, but also makes it easier for customers in the area to do business with us.”

The new CoE is fully equipped with the most advanced capabilities for process demonstration, testing and validation. Customers also can consult with Pall experts about equipment selection, installation and adjustment.

Integrated with the CoE at the Shanghai facility is a branch office that serves both the company’s Life Sciences and Industrial customers.

More than 200 employees work at the 8,600 m2 Shanghai facility, which provides filtration, separation and purification solutions for a range of industries. These include biopharmaceuticals, medical, food & beverage, process technologies, aerospace and microelectronics.

“China is an important market for Pall and long-term, favorable economic trends give us the confidence to continue development in the potentially high-growth region,” said Hang Gek Low, Vice President of Pall China.

Low continued, “The establishment of the Shanghai CoE enhances our ability to service customers in the area while enabling us to provide dedicated support for Chinese enterprises exploring overseas markets.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pall, Kaneka Enter Agreement
Pall Corporation announced the signing of a supply agreement for KANEKA KanCapA Japan for the primary capture of monoclonal antibodies from clarified cell culture.
Wednesday, January 20, 2016
Pall Corp. Signs Agreement with ATMI
Agreement to acquire ATMI’s LifeSciences business for $185 million.
Friday, December 27, 2013
Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)
The Centre of Excellence (COE) will offer a full suite of capabilities including cell culture, purification, analytical solutions, protein characterization and microbiological tools.
Monday, April 08, 2013
Pall Technology Enables Efficient Cell Harvest, Study Results Presented at International Cell Therapy Meeting
Pall system can be used to harvest cells from a broad range of biological samples including peripheral blood, bone marrow and umbilical cord blood.
Tuesday, May 09, 2006
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!